GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Burning Rock Biotech Ltd (NAS:BNR) » Definitions » NonCurrent Deferred Liabilities

Burning Rock Biotech (Burning Rock Biotech) NonCurrent Deferred Liabilities : $0.00 Mil (As of Sep. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Burning Rock Biotech NonCurrent Deferred Liabilities?

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Burning Rock Biotech's non-current deferred liabilities for the quarter that ended in Sep. 2023 was $0.00 Mil.

Burning Rock Biotech NonCurrent Deferred Liabilities Historical Data

The historical data trend for Burning Rock Biotech's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Burning Rock Biotech NonCurrent Deferred Liabilities Chart

Burning Rock Biotech Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
NonCurrent Deferred Liabilities
Get a 7-Day Free Trial 0.29 0.14 0.04 - -

Burning Rock Biotech Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Burning Rock Biotech NonCurrent Deferred Liabilities Related Terms

Thank you for viewing the detailed overview of Burning Rock Biotech's NonCurrent Deferred Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Burning Rock Biotech (Burning Rock Biotech) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Burning Rock Biotech Ltd (NAS:BNR) » Definitions » NonCurrent Deferred Liabilities
Comparable Companies
GTH BDSX FONR PRPH ENZ PRE VNRX SERA BIOQ LAB TMO DHR SHSE:603259 IDXX IQV A XSWX:LONN MTD ICLR ILMN
Traded in Other Exchanges
BNR:UK 6BUA:Germany
Address
No. 5, Xingdao Ring Road North, International Bio Island, Guangzhou, CHN, 510005
Website
https://www.brbiotech.com
Burning Rock Biotech Ltd is a cancer diagnostics company. Its products include OncoScreen Plus and ColonCore. The company has developed various cancer detection products, involving tumor targeting, differentiation of benign and malignant tumors, monitoring of small residual lesions, prediction of tumor recurrence progress, and detection of tumor sensitivity. It offers 12 NGS-based cancer therapy selection tests comprising a broad range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer, using both tissue and liquid biopsy samples.